# Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer

> **NCT00004195** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 28 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** eniluracil
- **PROCEDURE:** conventional colon surgery

## Key facts

- **NCT ID:** NCT00004195
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 1999-10
- **Final completion:** 2001-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004195, "Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00004195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*